Development of gene therapy and NGS-based diagnostic tests is a rapid way to transfer basis scientific findings into the clinical applications. VRISG is actively looking for the collaborator to implement the gene therapy to treat genetic diseases, such as hemophilia, hemophagocytic lymphohistiocytosis (HLH).